Co-Founder and Managing Partner

Michael Weintraub is Co-Founder and Managing Partner of Ardan Equity Partners, a healthcare enterprise software private equity firm.  Weintraub is Founding Chairman of Phreesia (NYSE: PHR), the leading patient intake company.  Previously, Michael served as Managing Partner of Optum Ventures, focused on digital health innovation.  Weintraub was Co-Founder and CEO of Humedica, a pioneer and leader in the field of population health management and big data.  Following Humedica’s acquisition by UnitedHealth Group (UHG), Michael broadened his role within UHG as President and CEO of Optum Analytics.  Prior to launching Humedica, Weintraub served as Senior Managing Director at Leerink Partners, a leading healthcare investment bank.  Michael also served as CEO of PharMetrics, a health care informatics company, which was acquired by IMS Health (now IQVIA).  Weintraub currently serves as Chairman of BroadReach Healthcare, a global healthcare company based in Cape Town, South Africa.  Michael serves as Chairman of Holmusk, a Behavioral Health Real World Evidence company. Weintraub is a member of the board of directors of Corrona, Oncology Analytics, NewFire Partners, and The College Diabetes Network (CDN).  Michael also focuses on healthcare innovation as an Entrepreneur in Residence at Harvard Business School.  Weintraub received his Bachelor’s Degree in Economics from Brandeis University and an MBA from Harvard Business School.